| Abstract: | Many cancers and neuro‐related diseases display significant phenotypic and genetic heterogeneity across subjects and subpopulations. Characterizing such heterogeneity could transform our understanding of the etiology of these conditions and inspire new approaches to urgently needed prevention, diagnosis, treatment, and prognosis. However, most existing statistical methods face major challenges in delineating such heterogeneity at both the group and individual levels. The aim of this article is to propose a novel statistical disease‐mapping (SDM) framework to address some of these challenges. We develop an efficient estimation method to estimate unknown parameters in SDM and delineate individual and group disease maps. Statistical inference procedures such as hypothesis‐testing problems are also investigated for parameters of interest. Both simulation studies and real data analysis on the ADNI hippocampal surface dataset show that our SDM not only effectively detects diseased regions in each patient but also provides a group disease‐mapping analysis of Alzheimer subgroups. |
